Physician profile
Marc D Webb
NPI 1508231721
$8,919.71
in general payments reported to CMS, 2019-2025
16 companies · $756 in 2025
The $756 reported for 2025 was more than what 75% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,532 · 2022: $727 · 2023: $2,475 · 2024: $430 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,348.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,312.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $6,463.47 | 2021-2024 | Spravato, Invega Sustenna |
| Abbvie INC. | $458.59 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $288.41 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Alkermes, INC. | $212.52 | 2022 | |
| Biogen, INC. | $196.18 | 2023 | |
| Averitas Pharma INC. | $149.98 | 2025 | Qutenza |
| Inspire Medical Systems, INC. | $142.97 | 2025 | Inspire |
| Neurocrine Biosciences, INC. | $131.00 | 2021 | |
| Corium, LLC | $125.00 | 2024 | Azstarys |
| Axsome Therapeutics, INC. | $124.92 | 2025 | Auvelity |
| Amgen INC. | $123.78 | 2025 | Krystexxa |
| E.R. Squibb & Sons, L.L.C. | $116.50 | 2025 | Cobenfy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.60 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $99.54 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $96.99 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $86.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.